NCT07853508

Brief Summary

Dysmenorrhea, or painful menstrual periods, is a common condition that can affect daily activities and quality of life. This study aims to evaluate whether using virtual reality (VR) can reduce pain and anxiety in women with primary dysmenorrhea. Participants will be randomly assigned to either a VR group or a 2D video group. Participants in the VR group will watch a relaxing virtual environment using a VR headset for 20 minutes once a day for three consecutive days. Participants in the 2D video group will watch the same content for the same duration and frequency using a 2D screen, such as a phone, tablet, or computer. Pain intensity and anxiety levels will be assessed before and after each session during the three-day intervention. The study will compare changes in pain and anxiety between the two groups to evaluate the effect of VR in women with primary dysmenorrhea.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Sep 2026Nov 2026

First Submitted

Initial submission to the registry

September 26, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

September 30, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2026

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

1 month

First QC Date

September 26, 2026

Last Update Submit

September 26, 2026

Conditions

Keywords

Primary DysmenorrheaVirtual RealityPainAnxietyWomen health

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale (VAS)

    This is used to quantify certain values that cannot be measured numerically. The two extremes of the parameter being evaluated are marked at either end of a 100 mm line, and the patient is asked to indicate their current status on this line by drawing a mark, placing a dot, or pointing. For pain assessment, "no pain" is written at one end and "severe pain" at the other; the patient then marks their current pain level on the line. The distance from the "no pain" end to the patient's mark represents the level of pain. Evaluation is performed by calculating the mean of the values obtained from the patients.

    1-3. days

Secondary Outcomes (1)

  • State Anxiety Inventory (STAI-X)

    1-3. days

Study Arms (2)

2D Video Group

ACTIVE COMPARATOR

Participants will watch the same 20-minute relaxation video on a conventional 2D screen (e.g., tablet, smartphone, or computer) once daily for three consecutive days during the first three days of menstruation. Pain intensity and state anxiety will be assessed immediately before and after each session.

Behavioral: Virtual Reality

Virtual Reality Group

EXPERIMENTAL

Participants will receive a 20-minute relaxation video through a virtual reality (VR) headset once daily for three consecutive days during the first three days of menstruation. Pain intensity and state anxiety will be assessed immediately before and after each session.

Behavioral: Virtual Reality

Interventions

Virtual RealityBEHAVIORAL

A 20-minute relaxation video will be presented using a virtual reality (VR) headset. Participants will receive the intervention once daily for three consecutive days during the first three days of menstruation. The VR environment is designed to provide an immersive visual and auditory experience and to direct participants' attention away from menstrual pain.

2D Video GroupVirtual Reality Group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen who self-identify as female are eligible to participate.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • University students,
  • Diagnosed with primary dysmenorrhea,
  • Having a regular menstrual cycle,
  • Willing to participate in the study,
  • Having no vision or hearing problems.

You may not qualify if:

  • Individuals diagnosed with secondary dysmenorrhea,
  • Individuals experiencing chronic pelvic pain,
  • Individuals with a psychiatric disorder,
  • Individuals using hormonal therapy,
  • Individuals using analgesics during menstruation,
  • Individuals with visual or hearing impairments,
  • Individuals wishing to withdraw at any stage of the study,
  • Individuals who fill out the forms incompletely or fail to fill them out.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Tokat Gaziosmanpasa University

Erbaa, Tokat Province, 60500, Turkey (Türkiye)

Location

Tokat Gaziosmanpasa University

Erbaa, Tokat Province, Turkey (Türkiye)

Location

MeSH Terms

Conditions

DysmenorrheaAnxiety DisordersPain

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainNeurologic ManifestationsSigns and SymptomsMental Disorders

Central Study Contacts

Abdurrahim Uyanık, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The study is open-label for participants, care providers, and investigators. The statistician/data analyst will be blinded to group allocation during the statistical analysis. Group assignments will be coded without identifying the intervention groups until the primary analyses have been completed.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either a virtual reality (VR) intervention group or a 2D video group. Both groups will receive a 20-minute relaxation video once daily for three consecutive days during the first three days of menstruation. The VR group will watch the content using a VR headset, while the 2D video group will watch the same content on a conventional screen. Pain intensity and state anxiety will be assessed immediately before and after each session. Thus, six repeated measurements will be obtained for each outcome over the three-day intervention period. Randomization will be performed using a computer-generated random sequence by an independent researcher who is not involved in the study procedures.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

September 26, 2026

First Posted

October 1, 2026

Study Start

September 30, 2026

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

October 1, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared with other researchers. De-identified aggregate data will be reported in publications resulting from this study.

Locations